Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.

Medartis Holding AG

Medartis is a company that specializes in medical technology, focusing on surgical solutions for the upper and lower extremities and the craniomaxillofacial region.

Medartis

Medartis LATAM

Medartis Inc. - United States

Medartis APAC

Medartis DACH

At Medartis, we develop, manufacture and distribute titanium screws and plates, surgical instruments and system solutions for fracture fixation. Headquartered in Basel, Switzerland, our company is represented worldwide through 12 subsidiaries and a wide distributor network.

We place the highest priority on maintaining stringent quality standards, continuous development and innovation, including comprehensive service provision for physicians, operating-room (OR) staff and patients. Our long-term customer relations based on partnerships have formed the foundation for our sustainable success since the company’s founding. 

Dr. h.c. Thomas Straumann founded Medartis in 1997 and returned to the field of osteosynthesis in cranio-maxillofacial surgery. Our product portfolio was expanded in 2004 with the APTUS Hand and Distal Radius systems. This paved the way for a successful entry into orthopedics.

All Medartis products are developed in close consultation with hand and traumatology specialists as well as experienced OR teams. Our goal is to continually improve early functional rehabilitation through our high-quality products and exclusively developed technologies. 

Corrective osteotomy of metacarpal malunion and fixation with a full threaded intramedullary screw CCS Medartis . Minimally invasive, no exposed hardware, immediate mobilisation, happy patient.

#handinstitutzürich #handsurgery #minimalinvasivehandsurgery #intramedullaryscrew

Thank you to everyone who joined us for the “Treatment Strategies for Lisfranc Joint Injuries and Pilon Fractures” session at JSFR 2024! Your participation made this event a huge success! 
A special thank you to our great chairperson, Dr. Satoru Ozeki, and our distinguished speakers, Dr. Naoki Haraguchi and Dr. Yohei Yanagisawa, for sharing their expertise and insights into advanced treatment strategies for foot and ankle fractures.
#Orthopedics #FootAndAnkle #LisfrancInjuries #PilonFractures #JSFR2024 #ContinuingEducation

Thank you to all participants for their engagement and interesting discussions at the #Symposium and the #Workshop at the #FESSH Congress. Special thanks to our speakers at the Symposium 𝗗𝗿. 𝗥𝗮𝗱𝗲𝗸 𝗞𝗲𝗯𝗿𝗹𝗲, 𝗗𝗿. 𝗚𝗲𝗿𝗻𝗼𝘁 𝗦𝗰𝗵𝗺𝗶𝗱𝗹𝗲 and 𝗗𝗿. Pascal Hannemann and the speakers at the Workshop 𝗗𝗿. 𝗡𝗶𝗲𝗹𝘀 𝗦𝗰𝗵𝗲𝗽 and 𝗣𝗗 𝗗𝗿. Philipp Honigmann.  

During the workshops, participants had the opportunity to enhance their skills using Medartis products from the #APTUS Hand and Wrist portfolio.

#Medartis #swissmade #FESSH2024 
FESSH | Federation of European Societies for the Surgery of the Hand

We are thrilled to share that our Medartis Distributor Meeting on June 25-26 in Noordwijkerhout, Netherlands, was a great success! A heartfelt thank you to all our dedicated distributors from EMEA and APAC who joined us. Your engagement and enthusiasm were instrumental in making this event truly special.

Together, we are poised for continued growth and success!
#MedartisDistributorMeeting #DistributorSuccess #MedartisFamily
#MedartisGrowth #SuccessTogether#Medartis

We’re thrilled to have supported the CadLab at the #WarsawTraumaCourse 2024 last weekend, organized by the European Association for Cranio-Maxillo-Facial Surgery (EACMFS) in Warsaw, Poland!
The focus on Cranio-Maxillo-Facial Traumatology and Management of Battle Injuries provided an invaluable platform to advance knowledge and skills in this critical area of trauma care. Big thanks to all participants and organizers for making it a tremendous success! 
Discover more about our innovative CMF solutions: https://lnkd.in/eQ7ECes3
#Medartis #CranioMaxilloFacial #TraumaCare #MedicalEducation #EACMFS #MedicalTraining

Just a few days left! We are looking forward to seeing you at the #FESSH Congress in #Rotterdam! You will find us at booth #14 where we are showcasing Medartis’ newest products and services. Our team, Helene H. Dietrich, Julia Rolwes, Anna Gab, Marijn Fauser, Christoph Engel, Andrea Erico G. Tami and many others, are excited to see you and looking forward to hearing about your experience with our products and any ideas you may have.

#medicaleducation #surgeon #orthopaedics #medicaldevice #hand #wrist

#fesshhandsinrotterdam FESSH | Federation of European Societies for the Surgery of the Hand

msh id	COM:MEDARTIS
symbol	MED
name	Medartis Holding AG
homepage url	https://www.medartis.com
country	CH
sector	-
industry	-
market	STOCKS
employee count	858
crunchbase url	-
linkedin url	-
founders	-

market cap	963.52M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.09
growth cost of revenue	0.27
growth depreciation and amortization	0.16
growth ebitda	1
growth ebitda ratio	0.72
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.15
growth gross profit	0.12
growth gross profit ratio	-0.03

COM:MEDARTIS

Medartis

Last Close

48.85

21/11 16:33

Market Cap

963.52M

Beta: -

Volume Today

2.57K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	221.47M
cost of revenue	221.47M
depreciation and amortization	23.19M
ebitda	35.82M
ebitda ratio	0.15
eps	0.06
eps diluted	0.06
operating expenses	154.72M
operating income	12.63M
operating income ratio	0.05

accounts receivables	-292.62K
capital expenditure	-20.77M
cash at beginning of period	22.75M
cash at end of period	27.83M
inventory	75.42M
working capital ttm	98.36M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-